Pharma News

Indias Biggest Pharma Expo in the National Capital

Indias Biggest Pharma Expo in the National Capital

Indian Pharma Expo 2019 is coming up on 16th, 17th & 18th July at Hall 12A Pragati Maidan, New Delhi.

New Delhi: India’s famous Pharma event “I...

Dr Reddys Laboratories announces the relaunch of Zenatane in the US Market

Dr Reddys Laboratories announces the relaunch of Zenatane in the US Market

Hyderabad, India and Princeton, NJ, USA. June 3, 2019 — Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred ...

Lupin in alliance with Natco receives FDA approval for Bosentan Tablets

Lupin in alliance with Natco receives FDA approval for Bosentan Tablets

Mumbai, Baltimore, April 30, 2019: Lupin Limited (Lupin) in alliance with Natco Pharma (Natco) announced that it has received approval for Bosentan Tablets, 62.5 mg and 125 mg, from the Unite...

Cipla receives final approval for generic version of Gilead Sciences Incs Letairis AmbrisentanTabs 5mg and 10mg

Cipla receives final approval for generic version of Gilead Sciences Incs Letairis AmbrisentanTabs 5mg and 10mg

Mumbai, India; April 30, 2019: – Cipla Limited and its subsidiary Cipla USA, Inc., (hereafter referred to as “Cipla”) announce receipt of final approval for the Abbreviated...

Cipla appoints Dr Raju Mistry as Global Chief People Officer

Cipla appoints Dr Raju Mistry as Global Chief People Officer

Mumbai, April 22, 2019 – Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announces the appointment of Dr. Raju Mistry as President and Globa...

Lupin receives FDA approval for Testosterone Gel

Lupin receives FDA approval for Testosterone Gel

Mumbai, Baltimore, April 11, 2019: Pharma major Lupin Limited (Lupin) announced that it has received approval for its Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation), from the United...

Lupin launches Fluoxetine Tablets USP

Lupin launches Fluoxetine Tablets USP

Mumbai, Baltimore, April 10, 2019: Pharma major Lupin Limited (Lupin) announced the launch of Fluoxetine Tablets USP, 60mg, having received an approval from the United States Food and Drug Ad...

Emcure launches worlds first generic Eribulin for treatment of metastatic breast cancer

Emcure launches worlds first generic Eribulin for treatment of metastatic breast cancer

Eribulin will be available in India at approximately 40% cost of the innovator brand

Emcure Pharmaceuticals, a leading integrated global pharmaceutical company from India ...

Previous Page Next Page
1 2 3 4 5 6 7 8 9 10